KINNATE BIOPHARMA INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • November 13th, 2020 • Kinnate Biopharma Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of [insert date], and is between Kinnate Biopharma Inc., a Delaware corporation (the “Company”), and [insert name of indemnitee] (“Indemnitee”).
KINNATE BIOPHARMA INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • November 13th, 2020 • Kinnate Biopharma Inc. • Pharmaceutical preparations • California
This Change in Control and Severance Agreement (the “Agreement”) is made by and between Kinnate Biopharma Inc., a Delaware corporation (the “Company”), and Mark Meltz (“Executive”), effective as of the Effective Date, as defined in Section 7 below.
OFFICE LEASEOffice Lease • November 13th, 2020 • Kinnate Biopharma Inc. • Pharmaceutical preparations • California
This Office Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between REALTY INCOME PROPERTIES 14, LLC, a Delaware limited liability company (“Landlord”), and FOUNT THERAPEUTICS, LLC, a Delaware limited liability company (“Tenant”).
Re: Confirmatory Employment LetterEmployment Letter Agreement • November 13th, 2020 • Kinnate Biopharma Inc. • Pharmaceutical preparations • California
This confirmatory employment letter agreement (the “Agreement”) is entered into between you and Kinnate Biopharma Inc. (the “Company” or “we”), effective as of the effective date of the Company’s registration statement relating to the Company’s initial public offering (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date.
KINNATE BIOPHARMA INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT August 24, 2020Investors’ Rights Agreement • November 13th, 2020 • Kinnate Biopharma Inc. • Pharmaceutical preparations • California
This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is dated as of August 24, 2020, and is between Kinnate Biopharma Inc., a Delaware corporation (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”).
Re: Confirmatory Employment LetterKinnate Biopharma Inc. • November 13th, 2020 • Pharmaceutical preparations • California
This confirmatory employment letter agreement (the “Agreement”) is entered into between you and Kinnate Biopharma Inc. (the “Company” or “we”), effective as of the effective date of the Company’s registration statement relating to the Company’s initial public offering (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date.
